Clinical trials with implications regarding heart failure therapy

Current Opinion in Cardiology

Volumn 12, Issue 4, 1997, Pages 407-417

  Young, James B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; INOTROPIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

ADRENERGIC SYSTEM; CARDIOVERSION; CLINICAL TRIAL; DEFIBRILLATOR; DRUG CONTRAINDICATION; HEART FAILURE; HEART VENTRICLE FUNCTION; HUMAN; META ANALYSIS; MORTALITY; MYOCARDITIS; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0030750413     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199707000-00010     Document Type: Review

References (20)

1. Australia-New Zealand Heart Failure Research Collaborative Group: Effects of carvedilol in patients with congestive heart failure due to ischemic heart disease: final results from the Australia-New Zealand Heart Failure Research Collaborative Group Trial. Lancet 1997, 349:387-380.
2. Cairns JA, Connolly SJ, Roberts R, Gent M: The Canadian amiodarone myocardial in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Lancet 1997, 349:675-682.
3. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH, for the US Carvedilol Heart Failure Study Group: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996, 334:1349-1355.
4. Colucci WS, Packer M, Bristow MR, Gilbert EM, Cohn JN, Fowler MB, Krueger SK, Hershberg R, Uretsky BF, Bowers JA, Sackner-Bernstein JD, Young ST. Holcslaw TL, Lukas MA, for the US Carvedilol Heart Failure Study Group: Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation 1996, 94:2800-2806.
5. Bristow MR, Gilbert EM, Abraham WT, Adams KF, Fowler MB, Hershberger RE, Kubo SH, Narahara KA, Ingersoll H, Krueger S, Young S, Shesterman N, for the MOCHA Investigators: Carvedilol produces dose related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation 1996, 94:2807-2816.
6. Packer M, Colucci WS, Sackner-Bernstein JD, Liang C-S, Goldscher DA, Freeman I, Kukin ML, Kinhal V, Udelson JE, Klapholz M, Gottlieb SS, Pearle D, Cody RJ, Gregory JJ, Kantrowitz NE, LeJemtel TH, Young ST, Lukas MA, Shusterman NH, for the PRECISE Study Group: Double-blind, placebo-controlled study of effects of carvedilol in patients with moderate to severe heart failure: The PRECISE trial. Circulation 1996, 94:2793-2799.
7. Singh SN, Fletcher RD, Fisher Gross S, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzeri D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure: Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995, 333:77-82.
8. The Digitalis Investigation Group: The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997, 336:525-533.
9. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Dawn EN, Snavely DB, Chang PI, on behalf of ELITE Study Investigators: Randomised trial of losartan versus captopril in patients over 65 with heart failure (evaluation of losartan in the elderly study, ELITE). Lancet 1997, 349:747-752.
10. Julian DG, Camm AJ, Frangin G, Janse MJ, Munoz A, Schwartz PJ, Simon P, for the European Myocardial Infarct Amiodarone Trial Investigators: Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. Lancet 1997, 349:667-674.
11. Gruppo Italiano per lo Studio della Sopravvivenza nell-Infarto Miocardico: GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994, 343:1115-1122.
12. International Study of Infarct Survival Research Group: Fourth International Study of Infarct Survival: a randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995, 345:669-685.
13. Moss AJ, Hall J, Cannom DS, Daubert JP, Higgins SL, Klein H, Levin JH, Sakensa SV, Waldo AL, Wilber D, Brown MW, Heo M, for the Multicenter Automatic Defibrillator Implantation Trial Investigators: Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med 1996, 335:1933-1940.
14. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, and the Myocarditis Treatment Trial Investigators: A clinical trial of immunosuppressive therapy for myocarditis. N Engl J Med 1995, 333:269-275.
15. The Pimobendan in Congestive Heart Failure (PICO) Investigators: Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) Trial. Heart 1996, 76:223-231.
16. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Neubert GW, Frid D, Wertheimer JH, Cropp AB, DeMets DL, for the Prospective Randomized Amlodpine Survival Evaluation Study Group: Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med 1996, 335:1107-1114.
17. Hampton JR, van Veldhuisen DJ, Kleber FX, Cowley AJ, Ardia A, Block P, Contina A, Cserhalmi L, Follath F, Jensen G, Kayanakis J, Lie KL, Mancia G, Skene AM: Second prospective randomised study of ibopamine on mortally and efficacy (PRIME II). Lancet 1997, 349:971-977.
18. Ambrosioni E, Borghi C, Magnani B, for the Survival of Myocardial Infarction Long-term Evaluation (SMILE) Study Investigators: The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995, 332:80-85.
19. Waldo AL, Camm AJ, deRuyter H, Friedman PL, Mac Neil DJ, Pauls JF, Pitt B, Pratt CM, Schwartz PJ, Veltri EP, for the SWORD Investigators: Effect of D-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996, 348:7-12.
20. Kober L, Torp-Pedersen C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, Videaek J, Cole DS, Auclert L, Pauly NC, Aliot E, Persson S, Camm AJ, for the Trandolapril Cardiac Evaluation (TRACE) Study Group: A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995, 333:1670-1676.